Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Patterns of Care Among Adolescents and Young Adults Treated for Acute Lymphoblastic Leukemia: A Retrospective Study across Diverse US Practices

Tarun Bhagnani, Michael Roth, Kristen M. O'Dwyer, Julie Wolfson, Indrani Chatterjee, Arun Prashar, Ravi Potluri, Eros Papademetriou, Robert Paglia, David Robert Freyer

Blood (2023) 142 (Supplement 1): 3704.

https://doi.org/10.1182/blood-2023-189553

Published: 2023

Journal Articles

Romidepsin Induces Durable Responses in Patients with Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma (AITL)

Barbara Pro, MD, Steven M. Horwitz, MD, H. Miles Prince, MB BS (Hons) MDFRACP FRCPA AFRACMA MACD, Francine M. Foss, MD, Lubomir Sokol, MD PhD, Matthew Greenwood, MD FRACP, FRCPA, Dolores Caballero, Franck Morschhauser, MD PhD, Martin Wilhelm, MD, Lauren Pinter-Brown, Prof, MD FACP, Swaminathan Padmanabhan Iyer, MD Dir, Hematological Malignancies, Andrei R. Shustov, MD, Julie Wolfson, MPH, Barbara E Balser, VMD, Bertrand Coiffier, MD PhD Prof

Blood (2014) 124 (21): 1742.

https://doi.org/10.1182/blood.V124.21.1742.1742

Published: 2014

Journal Articles

Impact of Care at NCI Comprehensive Cancer Centers (NCICCC) on Outcomes in Children, Adolescents and Young Adults (AYA) with Hematologic Malignancies

Julie Wolfson, MD MSHS, Can-Lan Sun, PhD, Laura Wyatt, BA, Wendy Stock, MD, Smita Bhatia, PhD

Blood (2014) 124 (21): 556.

https://doi.org/10.1182/blood.V124.21.556.556

Published: 2014

Journal Articles

Romidepsin Is Effective and Well-Tolerated In Patients ≥ 60 Years Old With Relapsed Or Refractory Peripheral T-Cell Lymphoma (PTCL): Analysis From Phase 2 Trials

Andrei R. Shustov, MD, Bertrand Coiffier, MD, PhD, Steven M. Horwitz, MD, Lubomir Sokol, MD, Ph.D, Barbara Pro, MD, Tina Nielsen, MD, PhD, Julie Wolfson, MPH, Barbara E Balser, VMD, Robin Eisch, RN, Leslie Popplewell, MD, Miles Prince, MD, FRACP, FRCPA, Steven L. Allen, M.D., Richard Piekarz, MD, PhD, Susan E. Bates, MD

Blood (2013) 122 (21): 4385.

https://doi.org/10.1182/blood.V122.21.4385.4385

Published: 2013

Journal Articles

Romidepsin Induces Durable Responses in Patients with Peripheral T-Cell Lymphoma: GPI-06–0002 Study Update

Bertrand Coiffier, MD, PhD, Barbara Pro, MD, Miles Prince, MD, FRACP, FRCPA, Francine M. Foss, MD, Lubomir Sokol, MD, Ph.D, Matthew Greenwood, MD, FRACP, FRCPA, Dolores Caballero, MD, Franck Morschhauser, MD, PhD, Martin Wilhelm, MD, Lauren Pinter-Brown, MD, Swaminathan Padmanabhan, MD, Andrei R. Shustov, MD, Tina Nielsen, MD, PhD, Jean Nichols, PhD, Julie Wolfson, MPH, Barbara E Balser, VMD, Steven M. Horwitz, MD

Blood (2012) 120 (21): 3641.

https://doi.org/10.1182/blood.V120.21.3641.3641

Published: 2012

Journal Articles

Exposure-QTc Response Analysis of Class 1 Selective Histone Deacetylase Inhibitor Romidepsin

C.J. Godfrey, PhD, Christopher H. Cabell, MD, MHS, FACC, Barbara Balser, VMD, Julie Wolfson, MPH, Jean Nichols, PhD, Howard A. Burris, III, MD

Blood (2011) 118 (21): 2680.

https://doi.org/10.1182/blood.V118.21.2680.2680

Published: 2011

Journal Articles

Preoperative Transfusion Practices and Outcomes in Sickle Cell Patients Admitted to California Hospitals,

Susan Claster, MD, Sheree M Schrager, MS, PhD, Vanessa Guzman, Julie Wolfson, MD, MSHS, Ellen Iverson, MPH

Blood (2011) 118 (21): 4189.

https://doi.org/10.1182/blood.V118.21.4189.4189

Published: 2011

Journal Articles

Use of Transfusion to Treat Acute Chest In Sickle Cell Disease:California Hospital Practice Patterns

Susan Claster, MD, Ellen Iverson, MPH, Sheree M Schrager, MS, PhD, Vanessa Guzman, Julie Wolfson, MD, MSHS

Blood (2010) 116 (21): 253.

https://doi.org/10.1182/blood.V116.21.253.253

Published: 2010

Journal Articles

California Emergency Department Utilization in Patients with Sickle Cell Disease: Sociodemographic Predictors.

Julie Wolfson, MD, MSHS, Sheree M Schrager, MS, PhD, Rachna Khanna, MPH, Thomas D. Coates, MD, Michele Kipke, PhD

Blood (2010) 116 (21): 3820.

https://doi.org/10.1182/blood.V116.21.3820.3820

Published: 2010

NARROW

Patterns of Care Among Adolescents and Young Adults Treated for Acute Lymphoblastic Leukemia: A Retrospective Study across Diverse US Practices

Romidepsin Induces Durable Responses in Patients with Relapsed or Refractory Angioimmunoblastic T-Cell Lymphoma (AITL)

Impact of Care at NCI Comprehensive Cancer Centers (NCICCC) on Outcomes in Children, Adolescents and Young Adults (AYA) with Hematologic Malignancies

Romidepsin Is Effective and Well-Tolerated In Patients ≥ 60 Years Old With Relapsed Or Refractory Peripheral T-Cell Lymphoma (PTCL): Analysis From Phase 2 Trials

Romidepsin Induces Durable Responses in Patients with Peripheral T-Cell Lymphoma: GPI-06–0002 Study Update

Exposure-QTc Response Analysis of Class 1 Selective Histone Deacetylase Inhibitor Romidepsin

Preoperative Transfusion Practices and Outcomes in Sickle Cell Patients Admitted to California Hospitals,

Use of Transfusion to Treat Acute Chest In Sickle Cell Disease:California Hospital Practice Patterns

California Emergency Department Utilization in Patients with Sickle Cell Disease: Sociodemographic Predictors.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only